Clinical Recommendations to Manage Gastrointestinal Adverse Events in Patients Treated with Glp-1 Receptor Agonists. Journal of Clinical Medicine
Jan 24, 2026 You have tried everything
To date, he has helped 141 patients achieve drug free, type 2 diabetes remission (achieving a remission rate of 51 per cent)
Supplied lyophilised reconstitute with bacteriostatic water, store at 28 C, and check the batch COA for purity and mass
Approximately 85% of participants on 5mg achieved at least 5% weight loss, and 69% achieved at least 10%
Safety and tolerability The safety profile was, as expected, dominated by gastrointestinal adverse events: nausea, vomiting, and diarrhea